Guangxi Liuzhou Pharm Co Ltd (603368) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.006x

Based on the latest financial reports, Guangxi Liuzhou Pharm Co Ltd (603368) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥45.64 Million ≈ $6.68 Million USD) by net assets (CN¥8.14 Billion ≈ $1.19 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Guangxi Liuzhou Pharm Co Ltd fund operations to measure how many days the company can operate on defensive assets alone.

Guangxi Liuzhou Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Guangxi Liuzhou Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Guangxi Liuzhou Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangxi Liuzhou Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Zhejiang Whwh SHG:600576	0.061x
TOA PAINT (THAILAND) BK:TOA-R	N/A
Xinjiang Baodi Mining Co. Ltd. A SHG:601121	N/A
INDIA SHELTER FINANCE CORPORATION LIMITED NSE:INDIASHLTR	-0.061x
New Pacific Metals Corp TO:NUAG	-0.005x
BKS Bank AG VI:BKS	-0.098x
Glotech Industrial TWO:5475	-0.015x
Supalai Public Company Limited BK:SPALI	0.027x

Annual Cash Flow Conversion Efficiency for Guangxi Liuzhou Pharm Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Guangxi Liuzhou Pharm Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see 603368 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥7.94 Billion ≈ $1.16 Billion	CN¥838.51 Million ≈ $122.70 Million	0.106x	+25.55%
2023-12-31	CN¥7.06 Billion ≈ $1.03 Billion	CN¥594.41 Million ≈ $86.98 Million	0.084x	+5.77%
2022-12-31	CN¥6.37 Billion ≈ $931.45 Million	CN¥506.43 Million ≈ $74.11 Million	0.080x	+38.77%
2021-12-31	CN¥5.81 Billion ≈ $849.64 Million	CN¥332.88 Million ≈ $48.71 Million	0.057x	-53.04%
2020-12-31	CN¥5.44 Billion ≈ $796.71 Million	CN¥664.69 Million ≈ $97.26 Million	0.122x	+37.70%
2019-12-31	CN¥4.66 Billion ≈ $681.54 Million	CN¥412.91 Million ≈ $60.42 Million	0.089x	+1508.91%
2018-12-31	CN¥4.05 Billion ≈ $592.21 Million	CN¥22.30 Million ≈ $3.26 Million	0.006x	+105.91%
2017-12-31	CN¥3.57 Billion ≈ $522.19 Million	CN¥-332.59 Million ≈ $-48.67 Million	-0.093x	-378.42%
2016-12-31	CN¥3.24 Billion ≈ $473.78 Million	CN¥108.39 Million ≈ $15.86 Million	0.033x	+142.47%
2015-12-31	CN¥1.36 Billion ≈ $199.10 Million	CN¥-107.25 Million ≈ $-15.69 Million	-0.079x	+30.12%
2014-12-31	CN¥1.17 Billion ≈ $171.78 Million	CN¥-132.42 Million ≈ $-19.38 Million	-0.113x	-353.08%
2013-12-31	CN¥501.00 Million ≈ $73.31 Million	CN¥22.33 Million ≈ $3.27 Million	0.045x	-72.11%
2012-12-31	CN¥378.59 Million ≈ $55.40 Million	CN¥60.51 Million ≈ $8.85 Million	0.160x	-67.14%
2011-12-31	CN¥274.23 Million ≈ $40.13 Million	CN¥133.38 Million ≈ $19.52 Million	0.486x	--

About Guangxi Liuzhou Pharm Co Ltd

SHG:603368 China Medical Distribution

Market Cap

$924.18 Million

CN¥6.32 Billion CNY

Market Cap Rank

#9449 Global

#2463 in China

Share Price

CN¥15.90

Change (1 day)

-0.62%

52-Week Range

CN¥15.77 - CN¥20.31

All Time High

CN¥62.90